Your browser doesn't support javascript.
loading
Prognostic nutritional index is an independent prognostic factor for treatment response, survival and drug choice in metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide.
Küçükarda, A; Gökyer, A; Gökmen, I; Özcan, E; Hacioglu, M B; Erdogan, B; Uzunoglu, S; Çiçin, I.
Affiliation
  • Küçükarda A; Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey. Electronic address: ahmetkucukarda22@gmail.com.
  • Gökyer A; Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey.
  • Gökmen I; Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey.
  • Özcan E; Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey.
  • Hacioglu MB; Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey.
  • Erdogan B; Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey.
  • Uzunoglu S; Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey.
  • Çiçin I; Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne, Turkey.
Actas Urol Esp (Engl Ed) ; 46(5): 301-309, 2022 06.
Article in En, Es | MEDLINE | ID: mdl-35256324

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Trofoterapia Main subject: Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate Type of study: Prognostic_studies Language: En / Es Journal: Actas Urol Esp (Engl Ed) Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Trofoterapia Main subject: Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate Type of study: Prognostic_studies Language: En / Es Journal: Actas Urol Esp (Engl Ed) Year: 2022 Type: Article